CDC Invest 2020 ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 3.3% 3.2% 3.9%  
Credit score (0-100)  0 0 54 54 50  
Credit rating  N/A N/A BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 -21.9 -5.8 -10.2  
EBITDA  0.0 0.0 -21.9 -5.8 -10.2  
EBIT  0.0 0.0 -21.9 -5.8 -10.2  
Pre-tax profit (PTP)  0.0 0.0 -48.5 -51.3 -57.7  
Net earnings  0.0 0.0 -48.5 -51.3 -57.7  
Pre-tax profit without non-rec. items  0.0 0.0 -48.5 -51.3 -57.7  

 
See the entire income statement

Balance sheet (kDKK) 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 -8.5 -59.8 -118  
Interest-bearing liabilities  0.0 0.0 1,516 1,562 1,609  
Balance sheet total (assets)  0.0 0.0 1,513 1,508 1,500  

Net Debt  0.0 0.0 1,503 1,554 1,609  
 
See the entire balance sheet

Volume 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 -21.9 -5.8 -10.2  
Gross profit growth  0.0% 0.0% 0.0% 73.5% -75.9%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 1,513 1,508 1,500  
Balance sheet change%  0.0% 0.0% 0.0% -0.4% -0.5%  
Added value  0.0 0.0 -21.9 -5.8 -10.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 -3.0  

Profitability 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -1.4% -0.4% -0.6%  
ROI %  0.0% 0.0% -1.4% -0.4% -0.6%  
ROE %  0.0% 0.0% -3.2% -3.4% -3.8%  

Solidity 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
Equity ratio %  0.0% 0.0% -0.6% -3.8% -7.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -6,870.1% -26,792.9% -15,774.5%  
Gearing %  0.0% 0.0% -17,939.6% -2,611.8% -1,369.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 3.5% 3.0% 3.0%  

Liquidity 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
Quick Ratio  0.0 0.0 0.0 0.0 0.0  
Current Ratio  0.0 0.0 0.0 0.0 0.0  
Cash and cash equivalent  0.0 0.0 13.2 7.6 0.4  

Capital use efficiency 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -1,508.5 -1,559.8 -1,617.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
N/A
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0